IRIS
ARBITRIO, Mariamena
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.614
AS - Asia 1.032
EU - Europa 815
SA - Sud America 173
Continente sconosciuto - Info sul continente non disponibili 116
AF - Africa 48
OC - Oceania 7
Totale 3.805
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.523
IT - Italia 448
SG - Singapore 374
CN - Cina 172
BR - Brasile 129
IN - India 118
GB - Regno Unito 94
DE - Germania 89
VN - Vietnam 77
HK - Hong Kong 56
CA - Canada 52
BD - Bangladesh 45
FI - Finlandia 37
ID - Indonesia 28
PK - Pakistan 27
JO - Giordania 25
SE - Svezia 24
NL - Olanda 21
SA - Arabia Saudita 18
MX - Messico 16
FR - Francia 14
ES - Italia 13
RU - Federazione Russa 13
IQ - Iraq 12
ZA - Sudafrica 11
CO - Colombia 10
CZ - Repubblica Ceca 10
EG - Egitto 10
TR - Turchia 10
UA - Ucraina 10
JP - Giappone 9
MY - Malesia 8
EC - Ecuador 7
IE - Irlanda 7
IR - Iran 7
LT - Lituania 7
NG - Nigeria 7
PE - Perù 7
PT - Portogallo 7
AE - Emirati Arabi Uniti 6
AR - Argentina 6
AU - Australia 6
KE - Kenya 6
KR - Corea 6
ET - Etiopia 5
GT - Guatemala 5
LB - Libano 5
MA - Marocco 5
RO - Romania 5
UZ - Uzbekistan 5
VE - Venezuela 5
CR - Costa Rica 4
CY - Cipro 4
EU - Europa 4
PH - Filippine 4
BG - Bulgaria 3
CL - Cile 3
HR - Croazia 3
JM - Giamaica 3
PL - Polonia 3
PR - Porto Rico 3
PS - Palestinian Territory 3
PY - Paraguay 3
SV - El Salvador 3
CH - Svizzera 2
HN - Honduras 2
IL - Israele 2
LK - Sri Lanka 2
NI - Nicaragua 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
TN - Tunisia 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AT - Austria 1
AZ - Azerbaigian 1
BO - Bolivia 1
CM - Camerun 1
GE - Georgia 1
KG - Kirghizistan 1
KZ - Kazakistan 1
MD - Moldavia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
SC - Seychelles 1
TL - Timor Orientale 1
TT - Trinidad e Tobago 1
Totale 3.694
Salva come PNG Salva come JPEG
Città #
San Jose 285
Singapore 180
Ashburn 174
Chandler 124
Santa Clara 76
Dallas 65
Munich 62
Chicago 54
Bengaluru 46
Hefei 46
Council Bluffs 45
London 45
Hong Kong 44
Beijing 41
Ho Chi Minh City 36
Milan 33
New York 28
Catanzaro 26
Turku 25
Lawrence 24
Princeton 24
Phoenix 23
Los Angeles 22
Naples 22
Amman 17
Jeddah 13
São Paulo 13
The Dalles 13
Boardman 12
Carbonia 12
Helsinki 12
Montreal 12
Parma 12
Rome 11
Bologna 10
Chennai 10
Hanoi 10
Ottawa 10
San Nicola Manfredi 10
Spezzano della Sila 10
Wilmington 10
Atlanta 9
Buffalo 8
Delhi 8
Irbid 8
Madrid 8
Seattle 8
Brooklyn 7
Frankfurt am Main 7
Kaunas 7
San Francisco 7
Santo Stefano di Rogliano 7
Tokyo 7
Cosenza 6
Da Nang 6
Ercolano 6
Stockholm 6
Afragola 5
Cardiff 5
Des Moines 5
Dhaka 5
Glasgow 5
Guatemala City 5
Hyderabad 5
Kuala Lumpur 5
Kyiv 5
Lahore 5
Lucknow 5
Nairobi 5
Olomouc 5
Pune 5
Redmond 5
Richmond 5
Riyadh 5
Sacramento 5
Tashkent 5
Addis Ababa 4
Ankara 4
Boston 4
Brescia 4
Catania 4
Charlotte 4
Denver 4
Dublin 4
Florianópolis 4
Islamabad 4
Johannesburg 4
Manchester 4
Marano Marchesato 4
Messina 4
Mexico City 4
Nicosia 4
Paris 4
Redwood City 4
Shanghai 4
Tanta 4
Thái Bình 4
Toronto 4
Tubarão 4
West Jordan 4
Totale 2.053
Salva come PNG Salva come JPEG
Nome #
Pharmacogenetics/Pharmacogenomics of Drug-Metabolizing Enzymes and Transporters 507
A Novel Bispecific T-Cell Engager (CD1a x CD3ε) BTCE Is Effective against Cortical-Derived T Cell Acute Lymphoblastic Leukemia (T-ALL) Cells 154
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 129
miR-22 suppresses DNA ligase III addiction in multiple myeloma 116
Identification of ADME genes polymorphic variants linked to trastuzumab-induced cardiotoxicity in breast cancer patients: Case series of mono-institutional experience 109
miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic review 101
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 88
DMET-Analyzer: automatic analysis of Affymetrix DMET Data 86
The First-In-Class Anti-AXL×CD3ε Pronectin™-Based Bispecific T-Cell Engager Is Active in Preclinical Models of Human Soft Tissue and Bone Sarcomas 84
A Prognostic and Carboplatin Response Predictive Model in Ovarian Cancer: A Mono-Institutional Retrospective Study Based on Clinics and Pharmacogenomics 84
Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma. (CO-FIRST AUTHOR) 84
Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid Rhamnetin 82
miR-21 antagonism abrogates Th17 tumor promoting functions in multiple myeloma 81
Identifying prognostic markers for multiple myeloma through integration and analysis of MMRF-CoMMpass data 81
Error-prone DNA repair pathways as determinants of immunotherapy activity: an emerging scenario for cancer treatment 80
Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia 80
A peroxisome proliferator-activated receptor gamma (PPARG) polymorphism is associated with zoledronic acid-related osteonecrosis of the jaw in multiple myeloma patients: analysis by DMET microarray profiling 78
Allometric scaling approaches for predicting human pharmacokinetic of a locked nucleic acid oligonucleotide targeting cancer-associated miR-221 76
DmetTM genotyping: Tools for biomarkers discovery in the era of precision medicine 76
TERRA G-quadruplex stabilization as a new therapeutic strategy for multiple myeloma 74
Exploiting MYC-induced PARPness to target genomic instability in multiple myeloma 71
Modeling UGT2B7 and NR1I3 genes through multilayer network to highlight hidden link with taxane neurotoxicity 69
From single level analysis to multi-omics integrative approaches: A powerful strategy towards the precision oncology 69
Genetic Biomarkers of Sorafenib Response in Patients with Hepatocellular Carcinoma 68
Bioinformatic challenges for pharmacogenomic study: tools for genomic data analysis 67
Autophagy and neuroprotection in astrocytes exposed to 6-hydroxydopamine is negatively regulated by NQO2: relevance to Parkinson’s disease 67
Risk Alleles for Multiple Myeloma Susceptibility in ADME Genes 67
Pharmacogenomic Profiling of ADME Gene Variants: Current Challenges and Validation Perspectives 64
Dose-Finding Study and Pharmacokinetics Profile of the Novel 13-Mer Antisense miR-221 Inhibitor in Sprague-Dawley Rats 63
Inhibition of EZH2 triggers the tumor suppressive miR-29b network in multiple myeloma 62
Pharmacogenomics biomarker discovery and validation for translation in clinical practice. 62
Mir-22 modulates lenalidomide activity by counteracting myc addiction in multiple myeloma 62
Mirnas and lncrnas as novel therapeutic targets to improve cancer immunotherapy 62
Genetic variants associated with Fabry disease progression despite enzyme replacement therapy 62
The New Microtubule-Targeting Agent SIX2G Induces Immunogenic Cell Death in Multiple Myeloma 60
Ethical Perspectives on Pharmacogenomic Profiling 56
Mmrf-commpass data integration and analysis for identifying prognostic markers 56
Integration of DNA Microarray with Clinical and Genomic Data 56
Pembrolizumab plus lenvatinib in advanced endometrial cancer: case report and systematic review of lung toxicity 55
Reprogrammed lipid metabolism in advanced resistant cancers: an upcoming therapeutic opportunity 54
Genetic variants associated with gastrointestinal symptoms in Fabry disease. 54
From Single Level Analysis to Multi-Omics Integrative Approaches: A Powerful Strategy towards the Precision Oncology 53
Development and validation of bioanalytical methods for LNA-i-miR-221 quantification in human plasma and urine by LC-MS/MS 49
The impact of PARP inhibitors in the whole scenario of ovarian cancer management: A systematic review and network meta-analysis 38
Polymorphisms and Pharmacogenomics of NQO2: The Past and the Future 33
null 31
Upregulation of ACHE and BACE2 genes by oleacein in Alzheimer's disease and neuroblastoma 27
TERRA G-quadruplex stabilization as a new therapeutic strategy for multiple myeloma 16
null 2
Totale 3.805
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.943
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.943
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022126 0 0 0 22 5 2 10 22 30 17 13 5
2022/2023376 54 28 29 10 42 30 5 28 40 42 47 21
2023/2024469 87 34 42 37 41 70 27 38 10 17 32 34
2024/2025843 74 20 28 42 51 109 51 53 51 22 149 193
2025/20261.502 102 147 128 164 148 76 202 83 160 137 97 58
2026/2027392 42 75 162 113 0 0 0 0 0 0 0 0
Totale 3.805